{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:03:57Z","timestamp":1792292637489,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10096-022-04518-0","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:07:53Z","timestamp":1667322473000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes and factors contributing to poor prognosis of Pneumocystis jirovecii pneumonia in HIV-negative patients: a cross-sectional retrospective study in a Chinese single center"],"prefix":"10.1007","volume":"42","author":[{"given":"Ju","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingcheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"12","key":"4518_CR1","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","volume":"22","author":"RB Weyant","year":"2021","unstructured":"Weyant RB et al (2021) Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother 22(12):1579\u20131592","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"4518_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/mmy\/myaa024","volume":"58","author":"M Bateman","year":"2020","unstructured":"Bateman M, Oladele R, Kolls JK (2020) Diagnosing Pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol 58(8):1015\u20131028","journal-title":"Med Mycol"},{"issue":"12","key":"4518_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.medcli.2019.01.010","volume":"152","author":"BP Braga","year":"2019","unstructured":"Braga BP, Prieto-Gonzalez S, Hernandez-Rodriguez J (2019) Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases. Med Clin (Barc) 152(12):502\u2013507","journal-title":"Med Clin (Barc)"},{"key":"4518_CR4","doi-asserted-by":"crossref","unstructured":"Gingerich AD, KA Norris, JJ Mousa (2021) Pneumocystis pneumonia: immunity, vaccines, and treatments. Pathogens 10(2)","DOI":"10.3390\/pathogens10020236"},{"issue":"10","key":"4518_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3855\/jidc.10357","volume":"12","author":"YT Lee","year":"2018","unstructured":"Lee YT, Chuang ML (2018) Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update. J Infect Dev Ctries 12(10):824\u2013834","journal-title":"J Infect Dev Ctries"},{"issue":"12","key":"4518_CR6","doi-asserted-by":"publisher","first-page":"ofab545","DOI":"10.1093\/ofid\/ofab545","volume":"8","author":"EG McDonald","year":"2021","unstructured":"McDonald EG et al (2021) On the treatment of pneumocystis jirovecii pneumonia: current practice based on outdated evidence. Open Forum Infect Dis 8(12):ofab545","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4518_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13613-020-00649-9","volume":"10","author":"L Ding","year":"2020","unstructured":"Ding L et al (2020) Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies. Ann Intensive Care 10(1):34","journal-title":"Ann Intensive Care"},{"issue":"9","key":"4518_CR8","doi-asserted-by":"publisher","first-page":"ofaa354","DOI":"10.1093\/ofid\/ofaa354","volume":"7","author":"W Mundo","year":"2020","unstructured":"Mundo W et al (2020) Lower mortality associated with adjuvant corticosteroid therapy in non-HIV-infected patients With Pneumocystis jirovecii pneumonia: a single-institution retrospective US cohort study. Open Forum Infect Dis 7(9):ofaa354","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"4518_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jinf.2014.02.015","volume":"69","author":"SJ Kim","year":"2014","unstructured":"Kim SJ et al (2014) Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection. J Infect 69(1):88\u201395","journal-title":"J Infect"},{"key":"4518_CR10","doi-asserted-by":"crossref","unstructured":"Takeuchi K, Y Yakushijin (2021) Pneumocystis jirovecii pneumonia prophylaxis for cancer patients during chemotherapy. Pathogens 10(2)","DOI":"10.3390\/pathogens10020237"},{"issue":"1","key":"4518_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","volume":"96","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF et al (2018) Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 96(1):52\u201365","journal-title":"Respiration"},{"key":"4518_CR12","doi-asserted-by":"publisher","first-page":"680108","DOI":"10.3389\/fpubh.2021.680108","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Risk factors of mortality from Pneumocystis pneumonia in non-HIV patients: a meta-analysis. Front Public Health 9:680108","journal-title":"Front Public Health"},{"issue":"3","key":"4518_CR13","doi-asserted-by":"publisher","first-page":"e13511","DOI":"10.1111\/tid.13511","volume":"23","author":"CD Mejia","year":"2021","unstructured":"Mejia CD et al (2021) Experience with a six-month regimen of Pneumocystis pneumonia prophylaxis in 122 HIV-positive kidney transplant recipients. Transpl Infect Dis 23(3):e13511","journal-title":"Transpl Infect Dis"},{"key":"4518_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fcimb.2020.00224","volume":"10","author":"A Dunbar","year":"2020","unstructured":"Dunbar A et al (2020) Epidemiology of Pneumocystis jirovecii pneumonia and (non-)use of prophylaxis. Front Cell Infect Microbiol 10:224","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"4518_CR15","doi-asserted-by":"publisher","first-page":"e0246296","DOI":"10.1371\/journal.pone.0246296","volume":"16","author":"TO Kim","year":"2021","unstructured":"Kim TO et al (2021) Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness. PLoS One 16(2):e0246296","journal-title":"PLoS One"},{"issue":"11","key":"4518_CR16","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10096-021-04227-0","volume":"40","author":"L Yang","year":"2021","unstructured":"Yang L et al (2021) Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy. Eur J Clin Microbiol Infect Dis 40(11):2305\u20132314","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4518_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12879-021-06124-5","volume":"21","author":"F Jin","year":"2021","unstructured":"Jin F, Xie J, Wang HL (2021) Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with pneumocystis pneumonia. BMC Infect Dis 21(1):441","journal-title":"BMC Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04518-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T03:05:14Z","timestamp":1673233514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04518-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["4518"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04518-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was carried out in accordance with the Helsinki Declaration and approved by the Institutional Review Board of Changhai Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}